256 Newsroom — Uganda's Digital News Infrastructure
Health

India’s HIV infections are rising quietly. Why twice-yearly lenacapavir matters

Share
India’s HIV infections are rising quietly. Why twice-yearly lenacapavir matters
Image · India Today

What the report says

The Central Drugs Standard Control Organisation CDSCO has permitted two Indian drugmakers to make generic lenacapavir without local clinical trials amid a steady and worrying rise of new HIV infections in many states in the country

Read the full report at India Today →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting